Literature DB >> 17945209

POINT: EPCA-2: a promising new serum biomarker for prostatic carcinoma?

Eleftherios P Diamandis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17945209     DOI： 10.1016/j.clinbiochem.2007.09.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN： 0009-9120            Impact factor:   3.281


× No keyword cloud information.
  5 in total

1.  Markers of dispute.

Authors:  Virginia Hughes
Journal:  Nat Med       Date:  2009-12       Impact factor: 53.440

2.  Cancer biomarkers: can we turn recent failures into success?

Authors:  Eleftherios P Diamandis
Journal:  J Natl Cancer Inst       Date:  2010-08-12       Impact factor: 13.506

3.  Genetic variants and family history predict prostate cancer similar to prostate-specific antigen.

Authors:  S Lilly Zheng; Jielin Sun; Fredrik Wiklund; Zhengrong Gao; Pär Stattin; Lina D Purcell; Hans-Olov Adami; Fang-Chi Hsu; Yi Zhu; Jan Adolfsson; Jan-Erik Johansson; Aubrey R Turner; Tamara S Adams; Wennuan Liu; David Duggan; John D Carpten; Bao-Li Chang; William B Isaacs; Jianfeng Xu; Henrik Grönberg
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

Review 4.  Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.

Authors:  George Botchorishvili; Mika P Matikainen; Hans Lilja
Journal:  Curr Opin Urol       Date:  2009-05       Impact factor: 2.309

5.  Markers for detection of prostate cancer.

Authors:  Raymond A Clarke; Horst J Schirra; James W Catto; Martin F Lavin; Robert A Gardiner
Journal:  Cancers (Basel)       Date:  2010-06-04       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.